# HCPCS Q0138: Injection, ferumoxytol, non-ESRD use

Medicare HCPCS Q0138 has a Medicare Part B payment limit of $0.33 per 1 MG under 2026 Q4 Medicare Part B drug (ASP) pricing, the same in every state.

Web page: https://www.med-reveal.com/rates/Q0138-hcpcs-fee-schedule
Section: Temporary, Administrative and Miscellaneous

## Medicare rates

| | Amount |
| --- | --- |
| National non-facility | $0.33 |
| National facility | $0.33 |
| Release | 2026 Q4 (effective 2026-10-01) |

## Related codes

- A9300: Exercise equipment — https://www.med-reveal.com/rates/A9300-hcpcs-fee-schedule
- A9999: Miscellaneous DME supply or accessory, not otherwise specified — https://www.med-reveal.com/rates/A9999-hcpcs-fee-schedule
- Q0091: Screening papanicolaou smear, obtaining/preparing/conveyance to lab — https://www.med-reveal.com/rates/Q0091-hcpcs-fee-schedule
- Q0111: Wet mounts, KOH preparations — https://www.med-reveal.com/rates/Q0111-hcpcs-fee-schedule
- Q4074: Iloprost, inhalation solution, FDA-approved final product, non-compounded — https://www.med-reveal.com/rates/Q4074-hcpcs-fee-schedule

Commercial negotiated rates for Q0138 by payer and state: https://www.med-reveal.com/solutions/rate-benchmarking

## Sources

- CMS Medicare fee schedules (2026 Q4): https://www.cms.gov/medicare/payment/fee-schedules